Skip to main content
. 2003 Mar;131(3):528–535. doi: 10.1046/j.1365-2249.2003.02083.x

Table 5.

Comparison of PR3 levels in different clinical subgroups

Fisher's PLSD, P-value
Vasc-pat versus HBD <0·0001 (s.)
Vasc-pat versus DC <0·0001 (s.)
Vasc-pat, remission versus smouldering 0·21 (n.s.)
Vasc-pat, severe outcome versus non-severe outcome 0·44 (n.s.)
Vasc-pat, relapse versus no relapse 0·74 (n.s.)

Vasc-pat = all vasculitis patients. HBD = healthy blood donors. DC = disease controls. Severe outcome = severe organ damage, start in dialysis or death due to vasculitic complications during 6 years’ follow-up. Relapse = at least one relapse during 6 years’ follow up. n.s. = non-significant, s. = significant.